首页> 外文期刊>Surgical Endoscopy >Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study
【24h】

Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study

机译:纯腹腔镜肝切除长期围手术期结果与肝细胞癌的开放性肝切除术:回顾性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Laparoscopic treatment for hepatocellular carcinoma (HCC) has increased. We retrospectively compared the perioperative and long-term oncological outcomes of laparoscopic liver resection (LLR) with those of open liver resection (OLR) for hepatocellular carcinoma (HCC) in well-matched patient groups using propensity score matching (PSM). Methods We reviewed medical records of patients with HCC who underwent liver resection between July 2007 and April 2016 at our center. In total, 2335 patients were included in this study and divided into LLR (n = 264) and OLR (n = 2071) groups. For group comparisons, 1:2 PSM was used with covariates of baseline characteristics, including tumor characteristics and surgical liver resection procedures. Results After PSM, there were 217 and 434 patients in the LLR and OLR groups, respectively. The LLR group had shorter hospital stays (8.9 vs. 14.8 days; P < 0.001) and lower postoperative morbidity (6.5% vs. 12.0%; P = 0.022). The 1-, 3-, and 5-year overall survival rates were 98.1%, 87.0%, and 78.6%, respectively, for the LLR group, and 98.3%, 90.8%, and 84.3%, respectively, for the OLR group (P = 0.570). The 1-, 3-, and 5-year disease-free survival rates were 81.0%, 62.0%, and 49.1%, respectively, for the LLR group, and 85.3%, 64.7%, and 56.2%, respectively, for the OLR group (P = 0.563). Conclusions Long-term oncological outcomes were comparable between LLR and OLR for selected patients. LLR was associated with multiple benefits, even for selected patients with cirrhosis who underwent major hepatectomy. LLR for HCC performed by an experienced surgeon could be considered a safe and feasible alternative to OLR for selected patients.
机译:背景腹腔镜手术治疗肝细胞癌(HCC)有所增加。我们回顾性比较围手术期和长期腹腔镜肝切除(LLR)与开放式肝切除的肿瘤病变的结果(OLR)肝细胞癌(HCC)使用倾向评分匹配(PSM)旗鼓相当的患者群体。方法回顾HCC患者谁在我中心接受了2007年7月和2016年4月间肝切除术的医疗记录。总共2335名患者纳入本研究,并分成LLR(N = 264)和OLR(N = 2071)的基团。对于组比较,1:2 PSM用的基线特征的协变量使用,包括肿瘤特征和外科肝切除术的程序。结果PSM后,有217两434例患者分别在LLR和OLR组。所述LLR组有缩短住院时间(8.9对比14.8天; P <0.001),降低术后发病率(6.5%对12.0%; P = 0.022)。 1,3,5年总生存率分别为98.1%,87.0%和78.6%,为LLR组,98.3%,90.8%和84.3%,为OLR组( P = 0.570)。 1,3,5年无病生存率分别为81.0%,62.0%和49.1%,为LLR组,85.3%,64.7%和56.2%,为OLR组(P = 0.563)。结论:长期肿瘤学结果LLR和OLR之间是可比的选择的患者。 LLR与多重利益相关,即使对于选定的肝硬化患者谁经历了重大的肝切除术。可以被认为是安全的,可行的替代OLR选定患者LLR肝癌执行由有经验的外科医生。

著录项

  • 来源
    《Surgical Endoscopy》 |2020年第2期|共10页
  • 作者单位

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

    Univ Ulsan Asan Med Ctr Dept Surg Coll Med Div Hepatobiliary Surg &

    Liver Transplan 388-1;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 诊断学;
  • 关键词

    Hepatocellular carcinoma; Pure laparoscopic liver resection; Laparoscopic major hepatectomy;

    机译:肝细胞癌;纯腹腔镜肝切除术;腹腔镜主要肝切除术;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号